Company / Working Capital
Amneal Pharmaceuticals, Inc. Working Capital History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$1.0B
FY2025
5-year range
$458.0M / $1.0B
FY2021-FY2025
Trend
+124.8%
vs FY2024
Sector context
#38 of 213
Health Care
What the data says
Amneal Pharmaceuticals, Inc.'s working capital of $1.0B is higher than 82% of companies in the Health Care sector (FY2025). Working Capital returned to growth in FY2025 after 4 years of decline, reaching $1.0B.
Based on SEC 10-K filings.
$1.0B in FY2025 with a 5-year CAGR of +3.3%. Top quartile in the Health Care sector.
Improved from $531M to $1.0B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +16.0%
- 5-Year CAGR
- +3.3%
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 213This company $1.0B Sector average $934.6M
▼
+10.2% above sector average
Key checks
Key Insights
- 5-year CAGR of +3.3%, indicating consistent growth.
- In FY2025, working capital increased 124.8% year-over-year.
- Ranks #38 out of 213 companies in the Health Care sector.
- Lowest working capital in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.0B | +124.8% |
| FY2024 | $458.0M | -13.8% |
| FY2023 | $531.3M | -19.4% |
| FY2022 | $659.0M | -21.8% |
| FY2021 | $842.9M | -3.6% |
| FY2020 | $874.6M | +32.6% |
| FY2019 | $659.8M | -10.0% |
| FY2018 | $732.8M | +54.3% |
| FY2017 | $475.1M | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026